Updated
Five issuers filed Form 8-K current reports with the SEC on November 18, 2026, according to EDGAR listings. The filers were Summit Therapeutics Inc., GeneDx Holdings Corp., ChronoScale Holdings Corp, SPAR Group, Inc. and Retension Pharmaceuticals, Inc. The listings carried only filer names and form types, so the events disclosed in the filings were not available to this scan and their nature is not known.